Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 22 March 2018


Samsca is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Type 2 Diabetes

Type 2 Diabetes

View the latest epidemiology data, patient perspectives, ADA and EASD recommendations, treatment options and more.



Learn about the complex factors influencing development of obesity.

+ 4 more

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/000980
Orphan designation No
Date First Approved 03-08-2009
Type Medicinal product subject to medical prescription
Marketing authorisation holder Otsuka Pharmaceutical Europe Ltd